Solid Biosciences files to sell 3,616 shares

Solid Biosciences submitted a Form 144 reporting a proposed sale of 3,616 shares of common stock to settle vested restricted stock units on 02/18/2026.

Rhea-AI Filing Summary

Solid Biosciences submitted a Form 144 reporting a proposed sale of 3,616 shares of common stock to settle vested restricted stock units on 02/18/2026.

The filing lists prior sales by the reporting person: 2,701 shares on 12/03/2025, 26,250 shares on 02/02/2026, and 10,905 shares on 02/04/2026. The securities are listed on NASDAQ.

Insights

Corporate Governance Analyst

Routine affiliate sale notice tied to vested RSUs; past transactions are disclosed.

The filing records a proposed resale of 3,616 shares on 02/18/2026

and discloses prior dispositions of 2,701, 26,250, and 10,905 shares on specified dates. This notice is procedural and documents affiliate liquidity events rather than new corporate actions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the SLDB Form 144 report?

The Form 144 reports a proposed sale of 3,616 shares to settle vested restricted stock units on 02/18/2026. It also lists prior dispositions by the reporting person on 12/03/2025, 02/02/2026, and 02/04/2026.

Who is selling shares in the SLDB Form 144?

The filing identifies the issuer and a reporting person at the address listed as the source of sales. The proposed sale of 3,616 shares is described as settlement of vested restricted stock units on 02/18/2026.

What prior insider sales are disclosed in the filing for SLDB?

The filing discloses three prior sales: 2,701 shares on 12/03/2025, 26,250 shares on 02/02/2026, and 10,905 shares on 02/04/2026. Each sale includes the sale date and share count as reported.

Are the shares listed in the Form 144 from compensation?

Yes. The Form 144 specifically states the 3,616 shares are associated with settlement of vested restricted stock units and are characterized as Compensation in the filing for 02/18/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 09:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001954991
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Solid Biosciences Inc.
SEC File Number	001-38360
Address of Issuer	500 Rutherford Avenue Charlestown MASSACHUSETTS 02129
Phone	(617)-337-4680
Name of Person for Whose Account the Securities are To Be Sold	Herzich Paul
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETRADE FINANCIAL CORPORATION 3 EDISON DRIVE ALPHARETTA GA 30005	3616	21057.05	83412695	02/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/18/2026	Settlement of vested restricted stock units	Issuer			3616	02/18/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Herzich Paul C/O SOLID BIOSCIENCES INC. 500 Rutherford Avenue Charlestown MA 02129	Common Stock	12/03/2025	2701	13802.11
Herzich Paul C/O SOLID BIOSCIENCES INC. 500 Rutherford Avenue Charlestown MA 02129	Common Stock	02/02/2026	26250	168968.63
Herzich Paul C/O SOLID BIOSCIENCES INC. 500 Rutherford Avenue Charlestown MA 02129	Common Stock	02/04/2026	10905	70246.07

144: Remarks and Signature

Remarks	The sale reported on this Form 144 was made to cover witholding taxes following the vesting of previously granted performance stock units pursuant to a durable sale instruction letter adopted by Mr. Herzich on August 16, 2024 effecting the sell-cover-election. The sale does not represent a discretionary trade by Mr. Herzich.
Date of Notice	02/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/16/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kimberly Cornwell as attorney-in-fact for Paul Herzich
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)